Millipore

Anti-Histone H3.3 Antibody, K27M mutant

#ABE419 · western blot

39
Citing papers
2.3k
Combined citations
Supplier page Find this product

Research areas

Glioma Diagnosis and Treatment35Chromatin Remodeling and Cancer11Neurofibromatosis and Schwannoma Cases10Epigenetics and DNA Methylation7Cancer Genomics and Diagnostics5Meningioma and schwannoma management4Brain Metastases and Treatment3MicroRNA in disease regulation3

Papers citing this product

1
H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesis
Nature Communications·2019·384 cit.·DOI
2
Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma
Nature Communications·2016·262 cit.·DOI
3
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy
The Journal of Experimental Medicine·2017·215 cit.·DOI
4
Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma
Acta Neuropathologica Communications·2017·172 cit.·DOI
5
A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas
Acta Neuropathologica·2014·147 cit.·DOI
6
Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomas
Acta Neuropathologica·2014·137 cit.·DOI
7
Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas
Journal of Neuro-Oncology·2019·127 cit.·DOI
8
The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation
Acta Neuropathologica Communications·2020·120 cit.·DOI
9
Comprehensive molecular characterisation of epilepsy-associated glioneuronal tumours
Acta Neuropathologica·2017·75 cit.·DOI
10
BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15-9 Fusions Are More Frequent in the Midline Than Within the Cerebellum
Journal of Neuropathology & Experimental Neurology·2015·74 cit.·DOI